October 2024 – Page 4 – Goldea Capital

Fortinet is the Only Leader Positioned as Highest in Ability to Execute for the Fourth Consecutive Year in the 2024 Gartner® Magic Quadrant™ for SD-WAN

Written by Customer Service on October 4, 2024. Posted in Public Companies.

Fortinet named a Leader in the 2024 Gartner Magic Quadrant for SD-WAN for the fifth year in a row SUNNYVALE, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) — John Maddison, Chief Marketing Officer at Fortinet“Fortinet has once again been named a Leader in the Gartner Magic Quadrant for SD-WAN, which we believe highlights our commitment to empowering customers with cutting-edge solutions. Fortinet is the only vendor recognized across five separate Magic Quadrant reports: SD-WAN, SSE, Single-Vendor SASE, Network Firewalls, and Enterprise Wired and Wireless LAN. And we will continue innovating across the Fortinet Security Fabric to meet the unique needs of the hundreds of thousands of customers that trust Fortinet around the world.” News Summary Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking...

ITW Schedules Third Quarter 2024 Earnings Webcast

Written by Customer Service on October 4, 2024. Posted in Public Companies.

GLENVIEW, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW) will issue its third quarter 2024 results on Wednesday, October 30, 2024 at 7:00 a.m. CDT. Following the release, ITW will hold its third quarter 2024 earnings webcast at 9:00 a.m. CDT. To access the webcast for the event, please click on the following link:ITW Q3 2024 Earnings Webcast If you are a participant on the conference call, please dial 1-888-660-6652 (domestic) or 1-646-960-0554 (international) 10 minutes prior to the 9:00 a.m. CDT start time. The passcode is “ITW.” Following the webcast, presentation materials and an audio webcast replay will be available at http://investor.itw.com. An audio-only replay will be available from October 30 through November 6 by dialing 1-800-770-2030 (domestic) or 1-609-800-9909 (international). The passcode...

Additional Acceptance Period begins for MiddleGround Capital’s Voluntary Public Takeover Offer to shareholders of STEMMER IMAGING AG

Written by Customer Service on October 4, 2024. Posted in Mergers And Acquisitions.

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. Shareholders can tender their shares during the additional acceptance period for EUR 48.00 per share in cash, which represents an attractive premium of approx. 52 percent to the closing price of the STEMMER IMAGING AG share on July 19, 2024. The additional acceptance period starts on October 5, 2024, and will end on October 18, 2024, at 24:00 hours (Frankfurt am Main local time). LEXINGTON, Ky., Oct. 04, 2024 (GLOBE NEWSWIRE) — The acceptance period for the voluntary public takeover offer (“Takeover...

HII Hosts Chairman of the Joint Chiefs of Staff at Newport News Shipbuilding

Written by Customer Service on October 4, 2024. Posted in Public Companies.

NEWPORT NEWS, Va., Oct. 04, 2024 (GLOBE NEWSWIRE) — HII (NYSE: HII) hosted Gen. Charles Q. Brown Jr., chairman of the Joint Chiefs of Staff, at the company’s Newport News Shipbuilding division Thursday. “I firmly believe that honing our warfighting skills has primacy in all we do,” Brown said. “It was great to see the hard work of the Navy’s shipbuilding team alongside our defense industry partners ensuring we maintain our edge through the construction of the next Ford-class carrier and Columbia-class submarine. These efforts provide our military with unmatched capabilities, reinforcing our ability to operate effectively across any mission, in any domain, and in any region of the world.” While at NNS, Brown visited shipbuilders and sailors on John F. Kennedy (CVN 79), saw construction progress on Virginia- and Columbia– class...

EXEL Industries: Number of shares and voting rights as of 08.31.2024

Written by Customer Service on October 4, 2024. Posted in Public Companies.

EXEL Industries A French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul – 51206 Epernay Cedex – FranceReims Companies Register (RCS): No. 095 550 356 Number of shares and voting rightsArticle 223-16 of the AMF regulation Date Total number of shares comprising the share capital Total number of voting rights August 31, 2024 6,787,900 Theoretical voting rights: 11,391,721 Exercisable voting rights*: 11,386,426 * After deduction of shares without voting rights Attachment EXEL Industries Droits de vote 2024.08.31_EN

BAB, Inc. Reports Results for 3rd Quarter FY 2024

Written by Customer Service on October 4, 2024. Posted in Earnings Releases And Operating Results.

DEERFIELD, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) — BAB, Inc. (OTCQB: BABB), announced its financial results for the third quarter ended August 31, 2024. For the quarter ended August 31, 2024 BAB had revenues of $872,000 and net income of $160,000, or $0.02 per share earnings, versus revenues of $937,000 and net income of $168,000, or a $0.02 per share, for the same quarter last year. Royalty revenue increased for the third quarter 2024 compared to third quarter 2023. Franchise fee revenue and License fee and other income and Marketing Fund revenue decreased in the third quarter ended August 31, 2024 compared to same quarter 2023. For the nine months ended August 31, 2024, revenues were $2,591,000 and net income was $405,000, or $0.06 per share, versus revenues of $2,547,000 and net income of $330,000, or $0.05 per share for the...

First Western Financial, Inc. to Report Third Quarter 2024 Financial Results on Thursday, October 24

Written by Customer Service on October 4, 2024. Posted in Public Companies.

DENVER, Oct. 04, 2024 (GLOBE NEWSWIRE) — First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in Denver, Colorado (“First Western”), announced today that it will release financial results for its third quarter ended September 30, 2024 after the markets close on Thursday, October 24, 2024. Management will hold a conference call at 10:00 a.m. Mountain Time/12:00 p.m. Eastern Time on Friday, October 25, 2024, to discuss First Western’s financial results. Analysts and investors may participate in the question-and-answer session. The conference call will be webcast live on the News & Events page of First Western’s investor relations website. Participants on the conference call will need to click on the Telephone Access link provided below, register for the conference call, and then they...

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

Written by Customer Service on October 4, 2024. Posted in Public Companies.

PRINCETON, NJ, Oct. 04, 2024 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced it has received preliminary approval for a tax credit from the New Jersey Technology Business Tax Certificate Transfer Program administered by the New Jersey Economic Development Authority (NJEDA). Sonnet received approval of its application to sell up to $8,143,144 of its New Jersey State net operating losses (NOLs) and $62,810 of its New Jersey State research and development (R&D) tax credits for proceeds of up to $0.795 million through the New Jersey Technology Business Tax Certificate Transfer Program, subject to execution of such sale. Sonnet also expects to receive a $0.7 million net cash refund from the...

CytoDyn Engages Syneos Health as CRO For Its Phase II Oncology Trial

Written by Customer Service on October 4, 2024. Posted in Public Companies.

VANCOUVER, Washington, Oct. 04, 2024 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that it has engaged Syneos Health as the contract research organization (“CRO”) for its upcoming Phase II oncology trial. The trial will evaluate the efficacy of leronlimab in patients with relapsed/refractory micro-satellite stable colorectal cancer (“CRC”). Syneos Health is a leading fully integrated biopharmaceutical solutions organization that supports customers in accelerating the delivery of life-saving therapies to market. Syneos Health leverages advanced data analytics and AI/ML capabilities to improve outcomes at every stage of the asset lifecycle,...

Golden Triangle Ventures Secures Full Operational Control of its Logistics Assets and Initiates Cash Flow

Written by Customer Service on October 4, 2024. Posted in Public Companies.

LAS VEGAS, Oct. 04, 2024 (GLOBE NEWSWIRE) — via IBN — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) is proud to announce a major milestone in the expansion of its logistics division through its wholly owned subsidiary, LE Logistics, LLC (“LE”). After months of diligent effort, LE Logistics has officially secured the registration and insurance for eight trucks now operating under the authority of the company’s recently formed partnership, West End Trucking, Inc. (“West End”). With these vehicles now fully operational and integrated into LE Logistics’ framework, shipping has officially commenced, marking the beginning of a consistent cash flow stream for the Company. LE Logistics will receive 100% of the income generated from the loads booked through...

Month: October 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice